These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23761268)

  • 1. Meningitis associated with strongyloidiasis in an area endemic for strongyloidiasis and human T-lymphotropic virus-1: a single-center experience in Japan between 1990 and 2010.
    Sasaki Y; Taniguchi T; Kinjo M; McGill RL; McGill AT; Tsuha S; Shiiki S
    Infection; 2013 Dec; 41(6):1189-93. PubMed ID: 23761268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent strongyloidiasis complicated by recurrent meningitis in an HTLV seropositive Peruvian migrant resettled in Italy.
    Zammarchi L; Montagnani F; Tordini G; Gotuzzo E; Bisoffi Z; Bartoloni A; De Luca A
    Am J Trop Med Hyg; 2015 Jun; 92(6):1257-1260. PubMed ID: 25846292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five cases of recurrent meningitis associated with chronic strongyloidiasis.
    Shimasaki T; Chung H; Shiiki S
    Am J Trop Med Hyg; 2015 Mar; 92(3):601-4. PubMed ID: 25548379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strongyloidiasis and Culture-Negative Suppurative Meningitis, Japan, 1993-2015.
    Mukaigawara M; Nakayama I; Gibo K
    Emerg Infect Dis; 2018 Dec; 24(12):2378-2380. PubMed ID: 30457540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal outcome in a patient under immunosuppressant therapy infected with human T-lymphotropic virus type 1 (HTLV-1), cytomegalovirus (CMV) and Strongyloides stercoralis: a case report.
    Ashida C; Kinoshita K; Nozaki Y; Funauchi M
    BMC Infect Dis; 2020 Jul; 20(1):470. PubMed ID: 32615937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive markers for development of strongyloidiasis in patients infected with both Strongyloides stercoralis and HTLV-1.
    Satoh M; Kiyuna S; Shiroma Y; Toma H; Kokaze A; Sato Y
    Clin Exp Immunol; 2003 Sep; 133(3):391-6. PubMed ID: 12930366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strongyloidiasis associated with human T-cell lymphotropic virus type I infection in a nonendemic area.
    Dixon AC; Yanagihara ET; Kwock DW; Nakamura JM
    West J Med; 1989 Oct; 151(4):410-3. PubMed ID: 2588581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steptococcus bovis meningitis and sepsis associated with Strongyloidiasis in an immunocompetent patient.
    Hager C; Abaaba C; Kerns F
    W V Med J; 2007; 103(5):19-21. PubMed ID: 18309863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics of Disseminated Strongyloidiasis, Japan, 1975-2017.
    Mukaigawara M; Narita M; Shiiki S; Takayama Y; Takakura S; Kishaba T
    Emerg Infect Dis; 2020 Mar; 26(3):401-408. PubMed ID: 32091375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial complications of strongyloidiasis: Streptococcus bovis meningitis.
    Link K; Orenstein R
    South Med J; 1999 Jul; 92(7):728-31. PubMed ID: 10414486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Septic Meningitis and Liver Abscess due to Hypermucoviscous Klebsiella pneumoniae Complicated with Chronic Strongyloidiasis in a Human T-lymphotropic Virus 1 Carrier.
    Hosoda T; Sakamoto M; Orikasa H; Kubomura A; Misaki T; Okabe N
    Intern Med; 2020 Jan; 59(1):129-133. PubMed ID: 31434825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Enterococcal meningitis due to strongyloidiasis with HTLV-1 carrier].
    Sugiura A; Fujimoto M; Saida Y
    Rinsho Shinkeigaku; 2006 Oct; 46(10):715-7. PubMed ID: 17323782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe strongyloidiasis complicated by meningitis and hydrocephalus in an HTLV-1 carrier with increased proviral load.
    Satoh M; Futami A; Takahira K; Kodaira M; Tanaka T; Kuriki K; Hori E
    J Infect Chemother; 2003 Dec; 9(4):355-7. PubMed ID: 14691660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strongyloides stercoralis: a cause of morbidity and mortality for indigenous people in Central Australia.
    Einsiedel L; Fernandes L
    Intern Med J; 2008 Sep; 38(9):697-703. PubMed ID: 19143887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissemination of Strongyloides stercoralis as an immune restoration phenomenon in an HIV-1-infected man on antiretroviral therapy.
    Brown M; Cartledge JD; Miller RF
    Int J STD AIDS; 2006 Aug; 17(8):560-1. PubMed ID: 16925906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Report of a case of strongyloidiasis with a coinfection by HTLV-1 and onychomycosis].
    Alvarez-Falconí PP; Moncada-Vilela Z; Montero-Navarrete S; Hernandez-García JA
    Rev Gastroenterol Peru; 2013; 33(4):348-51. PubMed ID: 24419034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Human T-lymphotropic virus 1 (HTLV-1), strongyloidiasis and scabies. Infections and associations to considerate].
    Freites A
    Invest Clin; 2008 Dec; 49(4):455-6. PubMed ID: 19245164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Streptococcus bovis bacteremia and meningitis associated with Strongyloides stercoralis colitis in a patient infected with human immunodeficiency virus.
    Jain AK; Agarwal SK; el-Sadr W
    Clin Infect Dis; 1994 Feb; 18(2):253-4. PubMed ID: 8161638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe and treatment resistant strongyloidiasis--indicator of HTLV-I infection.
    Jeyamani R; Joseph AJ; Chacko A
    Trop Gastroenterol; 2007; 28(4):176-7. PubMed ID: 18416349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and immunological consequences of the association between HTLV-1 and strongyloidiasis].
    Porto MA; Muniz A; Oliveira Júnior J; Carvalho EM
    Rev Soc Bras Med Trop; 2002; 35(6):641-9. PubMed ID: 12612748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.